IL-1β is considered a biomarker of bacteria-associated exacerbation of COPD, and TNF-α and IL-6 are the potential markers of IL-1β-associated exacerbation of COPD (Bafadhel et al., 2011; Damera et al., 2016). This evidence concerns the gene IL6 and chronic obstructive pulmonary disease.